Form 4: Regency Centers Corp: Director C. Ronald Blankenship Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director C. Ronald Blankenship reports multiple transactions involving Regency Centers Corp common stock, including vesting of restricted stock, settlement of dividend equivalent rights, and receipt of director's fees in stock.

Summary

  • C. Ronald Blankenship, a director of Regency Centers Corp, filed a Form 4 detailing changes in beneficial ownership.
  • On May 5, 2025, Blankenship acquired 2,284 shares of common stock through the vesting of restricted stock.
  • Additionally, 91 shares were acquired through the settlement of dividend equivalent rights related to the vested restricted stock.
  • Blankenship also acquired 481 shares as director's fees paid in stock.
  • Following these transactions, Blankenship directly owns 110,918 shares of Regency Centers Corp common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transactions reflect standard compensation practices and ongoing investment by a director, which is generally viewed favorably.

Positives

  • The vesting of restricted stock and settlement of dividend equivalent rights indicate that the director is meeting performance or time-based milestones.
  • Receipt of director's fees in stock aligns the director's interests with those of the shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the director's ongoing investment in the company.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
  • The transactions reported are typical for directors receiving stock-based compensation and accumulating shares over time.

Stakeholder Impact

  • The transactions have a minor positive impact on shareholders by aligning the director's interests with theirs.
  • The transactions have no significant impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
05/05/2025Vesting of restricted stock, settlement of dividend equivalent rights, and receipt of director's fees in stock.
05/07/2025Date of signature on the Form 4 filing.

Keywords

Form 4, Regency Centers Corp, Blankenship, Director, Stock, Beneficial Ownership, Restricted Stock, Dividend Equivalent Rights

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.